Showing results (2301-2310 of 2,528) with videos related to

Sort By:
Pageof 253
The Lancet. Haematology|November 26, 2020
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trialMurielle Roussel, Philippe Moreau, Benjamin Hebraud, et al.
Investigational New Drugs|March 21, 2022
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinomaSteven F Powell, Miroslaw Mazurczak, Elie G Dib, et al.
Journal of the American Heart Association|April 16, 2025
Stroke Outcomes in a Population-Focused Urban Hypertension Program in Brazil and SenegalJose Maria E Ferrer, Johannes Boch, Ann Aerts, et al.
Nature Communications|May 6, 2025
Perinatal SSRI exposure impacts innate fear circuit activation and behavior in mice and humansGiulia Zanni, Milenna T van Dijk, Martha Caffrey Cagliostro, et al.
Diabetes Research and Clinical Practice|December 25, 2016
Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical dataFernando M A Giuffrida, Regina S Moises, Leticia S Weinert, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2020
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patientsConstance Chapuis-Biron, Anne Bourrier, Maria Nachury, et al.
Pediatric Research|December 19, 2023
Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)Eleanor J Molloy, Mohamed El-Dib, Janet Soul, et al.
JCO Precision Oncology|June 14, 2023
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry StudyApar K Ganti, Michael Rothe, Pam K Mangat, et al.
Journal of Crohn'S & Colitis|January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort StudyAntoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Molecular and Cellular Endocrinology|March 31, 2019
Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitusJuliana Doblas Massaro, Claudia Danella Polli, Matheus Costa E Silva, et al.
Pageof 253